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Abstract
Background: Clonidine effectively decreases perioperative mortality by reducing sympathetic tone. However,
application of clonidine might also restrict anaemia tolerance due to impairment of compensatory mechanisms.
Therefore, the influence of clonidine induced, short-term sympathicolysis on anaemia tolerance was assessed in
anaesthetized pigs. We measured the effect of clonidine on anaemia tolerance and of the potential for
macrohemodynamic alterations to constrain the acute anaemia compensatory mechanisms.
Methods: After governmental approval, 14 anaesthetized pigs of either gender (Deutsche Landrasse, weight
(mean ± SD) 24.1 ± 2.4 kg) were randomly assigned to intravenous saline or clonidine treatment (bolus: 20 μg · kg−1,
continuous infusion: 15 μg · kg−1 · h−1). Thereafter, the animals were hemodiluted by exchange of whole blood for 6 %
hydroxyethyl starch (MW 130.000/0.4) until the individual critical haemoglobin concentration (Hbcrit) was reached.
Primary outcome parameters were Hbcrit and the exchangeable blood volume (EBV) until Hbcrit was reached.
Results: Hbcrit did not differ between both groups (values are median [interquartile range]: saline: 2.2 (2.0–2.5) g · dL
−1
vs. clonidine: 2.1 (2.1–2.4) g · dL−1; n.s.). Furthermore, there was no difference in exchangeable blood volume (EBV)
between both groups (saline: 88 (76–106) mL · kg−1 vs. clonidine: 92 (85–95) mL · kg−1; n.s.).
Conclusion: Anaemia tolerance was not affected by clonidine induced sympathicolysis. Consequently, perioperative
clonidine administration probably has not to be omitted in view of acute anaemia.
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Background
Allogeneic blood transfusions are expensive and, though
safer than ever before, are still associated with potential
infectious, immunologic, and immunosuppressive risks.
Therefore one pillar of modern patient blood manage-
ment concepts is to decrease the number of periopera-
tive blood transfusions by accepting low intraoperative
haemoglobin concentrations without endangering tissue
oxygenation. However, this decline of oxygen carrying
capacity has to be compensated for by an increase of
cardiac output, organ perfusion, and oxygen extraction
ratio [1–3]. As long as these compensatory mechanisms
can be utilized, remarkable degrees of anaemia can be
survived, and less severe anaemia can be sustained with-
out significant sequelae [4].
Presently, a considerable number of patients are treated
with perioperative α2-agonists, either for sympathicolysis
to reduce perioperative cardiac risk or for sedation during
ICU hospitalization [5]. Perioperative α2-adrenergic ago-
nists decrease global oxygen consumption [6] and improve
perioperative myocardial morbidity and mortality [7, 8] by
increasing coronary perfusion especially in ischemic heart
disease [9], by improving coronary reserve, and by
decreasing oxygen consumption [6, 10]. Furthermore, they
are widely used for postoperative sedation in the ICU [11].
However, the influence of clonidine induced cardiovas-
cular alterations on acute anaemia tolerance is currently
unknown. Therefore we determined the effect of clonidine
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on anaemia tolerance and haemodynamic compensatory
mechanisms of acute anaemia in a pig model of acute nor-
movolemic hemodilution.
Methods
The experimental protocol was approved by the Animal
Care Committee (Regierungspräsidium Darmstadt, Hessen,
F 143/18). The experiments were performed in 14 pigs
(Deutsche Landrasse) of either sex (mean body weight
24.1 ± 2.4 kg). The animals were treated in accordance with
the Principles of Laboratory Animal Care (National Insti-
tute of Health publications 86–23, 1985).
Anaesthesia
Food was withheld one night prior to anaesthesia, but ani-
mals had free access to water. Midazolam (1.5 mg · kg−1)
and ketamine (10 mg · kg−1) were administered intramus-
cularly prior to anaesthesia. Anaesthesia was induced with
intravenous fentanyl (0.01 mg · kg−1), propofol (2 mg · kg
−1), and vecuronium bromide (0.3 mg · kg−1) and main-
tained by continuous intravenous fentanyl (0.045 mg · kg
−1 · h−1), propofol (10 mg · kg−1 · h−1), and midazolam
(0.6 mg · kg−1 · h−1) infusion. Vecuronium bromide
(1.0 mg · kg−1 · h−1) was administered continuously to
maintain muscular relaxation and minimize muscular
oxygen consumption. Estimated insensitive fluid losses
were compensated for by intravenous administration of
isotonic electrolyte solution (3 mL−1 · kg−1 · h−1; Sterofun-
din® ISO, B. Braun Melsungen AG, Melsungen, Germany).
A warming blanket (Warm Touch, Mallinckrodt/Convi-
dien; Boulder, CO, USA) was used to maintain constant
body temperature (baseline temperature ± 0.25 °C).
Animals were intubated endotracheally and mechanically
ventilated (FiO2 0.21) at a rate of 12–15 min
−1 and a
positive end-expiratory pressure of 5 cmH2O. The minute
volume was adjusted to maintain normocapnia, which was
confirmed by multiple blood gas analyses.
Instrumentation and monitoring
All animals were placed in supine position. A 12-lead
electrocardiogram was recorded continuously during the
entire experiment. Several intravascular catheters were
placed using Seldinger’s technique to avoid stress related
to surgical preparation. A Picco thermodilution catheter
(PICCO Pulsiocath, PULSION Medical Systems AG,
Munich, Germany) was placed in the right femoral artery
to measure arterial pressure and continuously measure
cardiac output.
A 20-gauge catheter was placed in the left femoral artery
for phlebotomy, and a 16-gauge catheter inserted into a
femoral vein to administer hydroxyethyl starch during
hemodilution. A 16-gauge catheter was inserted through
the left external jugular vein into the upper vena cava to
administer anaesthetic agents and monitor central venous
pressure; a pulmonary arterial catheter (7.5 Fr, Edwards
Swan-Ganz, Baxter Healthcare, Irvine, CA) was inserted
to sample mixed venous blood and monitor pulmonary
arterial pressure. The catheter positions were verified by
blood gas analysis and radiography.
Experimental protocol
After instrumentation, a 60-min stabilization period was
allowed for VO2 stabilization (see: Determination of
Hbcrit) before the first set of data was collected (baseline,
BL1). Blood volume was determined by indocyanine green
dilution kinetics using the “whole blood method”[12]. The
animals were then randomized into two experimental
groups comprising seven animals each.
After randomization animals received either 20 μg · kg−1
clonidine over a 10-min period (clonidine group) or an
equal volume of saline (control group) according to
randomization. Thereafter, 15 μg · kg−1 · h−1 clonidine or
the equal amount of saline was administered intraven-
ously. After the initial bolus, a 60-min stabilization period
elapsed, and a second set of data set was collected (BL2).
After baseline 2 (BL2) all animals were hemodiluted
isovolemically with HES 6 % (MW 130.000/0.4) at an
exchange rate of 1 mL · kg−1 · min−1 with a infuse/with-
drawal dual syringe pump (Harvard Apparatus, Holliston,
MA, US) until the critical haemoglobin concentration
(Hbcrit) was reached. The hemodilution procedure was
performed in steps of 200 ml, after which a short break for
hemodynamic measurements took place. This procedure
was repeated until the critical haemoglobin concentration
(time point Hbcrit) was detected. Hbcrit was defined as a
significant decrease in total body VO2 compared to the
baseline value (see: Determination of Hbcrit). The total
blood volume that was exchanged to reach Hbcrit was des-
ignated as the exchangeable blood volume (EBV).
Measurements
Arterial and mixed venous PO2 and PCO2, pH, electro-
lytes, haematocrit and arterial serum lactate concentration
was measured using a blood analysing system (Premier
GEM 3000, Instrumentation Laboratory, Lexington, MA,
USA). Haemoglobin concentration (Hb) and arterial
haemoglobin-oxygen saturation (SaO2) were measured by
spectrophotometry adjusted to swine haemoglobin (682
CO-Oximeter, Instrumentation Laboratory, Lexington,
MA, USA). Oxygen transport and uptake were calculated
as described in the Appendix.
Data analysis
Six experimental data sets were used for calculations, de-
fined as the baseline measurement (BL1), after clonidine
medication (second baseline, after medication, BL2) and
when 25, 50, 75, and 100 % of exchangeable blood volume
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(EBV) until Hbcrit were exchanged. These parameters are
summarized in Table 2.
The main outcome parameter of the study was the critical
haemoglobin concentration (Hbcrit) and the exchangeable
blood volume (EBV) until Hbcrit was reached. Secondary
outcome parameters were several macrohemodynamic,
oxygen transport, and tissue oxygenation parameters.
Determination of Hbcrit
In steady state, tissue oxygen consumption (VO2) equals
oxygen demand. However, when DO2 decreases (e.g. by he-
modilution) below a critical value, VO2 becomes oxygen
supply-dependent and decreases (Table 1, Fig. 1a). This
sudden VO2 decrease reflects the onset of global tissue
hypoxia [13], and the corresponding haemoglobin concen-
tration is called the “critical” Hb concentration (Hbcrit).
Previous studies found that 100 % of animals died within
3 h after achieving Hbcrit [14].
Total body VO2 was measured non-invasively at 1-min
intervals using a DeltaTrac metabolic monitor (DeltaTrac
IITM MBM-200, Datex, Helsinki, Finland) connected to
the ventilator. Hbcrit was automatically detected using
computer software especially designed for this purpose
(DeltaCrit System) [15]. VO2 values collected during the
Table 1 Macrohemodynamics
Group BL1 BL2 25 % 50 % 75 % Hbcrit
HR Saline 88 (87–107) 84 (83–107)** 91 (84–109)** 107 (85–113) 128 (95–132) 130 (98–142)**
bpm Clonidine 88 (79–114) 57 (53–62)** 64 (63–76)** 83 (79–88) 96 (91–116) 95 (94–101)**
MAP Saline 88 (69–107) 87 (70–105)** 87 (69–99) 87 (70–96) 80 (64–93) 53 (48–59)
mmHg Clonidine 85 (75–90) 113 (104–124)** 91 (83–99) 85 (79–88) 67 (66–79) 46 (27–52)
CI Saline 5,9 (5,4-6,3) 6,0 (5,6-6,3)** 6,1 (5,4-6,9)** 6,9 (6,5-8,1)** 7,3 (7,0-8,5) 7,9 (7,4-8,5)

























PVRI Saline 281 (276–332) 317 (284–361) 224 (205–308) 209 (194–221) 205 (190–264) 162 (135–173)
dyn sec cm−5m−2 Clonidine 316 (262–389) 379 (327–457) 271 (248–360) 278 (262–285) 231 (225–248) 139 (123–177)
CPP Saline 62 (43–71) 60 (46–70)** 51 (41–63) 41 (37–61) 32 (32–58) 23 (13–27)
mmHg Clonidine 49 (43–62) 77 (71–84)** 53 (47–61) 46 (37–53) 35 (25–40) 6 (2–16)
LVPsys Saline 121 (85–127) 122 (86–126)** 109 (87–121)** 102 (85–115) 95 (82–113) 77 (74–80)
mmHg Clonidine 105 (101–113) 143 (138–157)** 121 (117–130)** 114 (106–119) 100 (90–108) 70 (52–89)
LVPedp Saline 12 (12–15) 13 (12–15)** 15 (13–19)** 16 (16–19)** 16 (15–17) 17 (16–23)
mmHg Clonidine 11 (9–19) 16 (15–29)** 17 (16–26)** 19 (18–26)** 14 (12–22) 22 (18–26)
MPAP Saline 22 (21–27) 23 (22–32) 24 (22–31) 25 (22–31) 26 (22–32) 26 (24–34)
mmHg Clonidine 25 (23–27) 26 (24–27) 25 (24–29) 27 (25–32) 30 (25–31) 27 (25–29)
LVPdtpmax Saline 2210 (1705–2555) 2160 (1750–2528) 2400 (1950–3220) 2830 (2510–3630) 3630 (2748–3925) 2080 (1810–2805)

























LVSWI Saline 642 (595–820) 688 (604–825) 686 (595–790) 752 (671–896) 686 (642–749) 631 (393–668)
Nm 10−3m−2 Clonidine 435 (347–657) 610 (516–962) 717 (590–897) 664 (602–819) 609 (504–751) 409 (258–616)
RVSWI Saline 155 (148–216) 210 (172–231) 203 (178–238) 253 (190–286) 241 (178–272) 284 (231–299)
Nm 10−3m−2 Clonidine 125 (116–200) 148 (119–229) 233 (169–264) 209 (179–282) 203 (186–292) 271 (229–346)
Parameters of macrohemodynamics. All values are presented as median and quartiles (Q1-Q3) for the investigated time points BL1 (baseline, premedication), BL2
(second baseline, after medication), 25 % (exchange of 25 % of exchangeable blood volume (EBV)), 50 % (exchange of 50 % of EBV), 75 % (exchange of 75 % of
EBV), Hbcrit (critical haemoglobin concentration). **: p < 0.05 Saline vs. Clonidine
HR heart rate, MAP mean arterial pressure, CI cardiac output indexed to BSA, SVRI systemic vascular resistance indexed to BSA, PVRI pulmonary vascular resistance
indexed to BSA, CPP coronary perfusion pressure, LVPsys systolic left ventricular pressure, LVPedp enddiastolic left ventricular pressure, MPAP mean pulmonary
arterial pressure, LVPdtpmax maximum left ventricular pressure increase, LVPdtpmin maximum left ventricular pressure decrease, LVSWI left ventricular stroke work
index, RVSWI right ventricular stroke work index
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60-min stabilization period were included in an online
regression analysis. The VO2 values measured during
hemodilution were compared to the mean value predicted
by the DeltaCrit system; if the measured value was outside
a predefined range (3 × SD of the regression line), the VO2
was considered significantly decreased, and the computer
alerted visually and acoustically. This time point was des-
ignated as Hbcrit (Fig. 1b).
Statistical analysis
Prior to the study, a sample size analysis was conducted
using a software package (PS, Power and Sample Size Cal-
culation, Version 3.0, 2009, Vanderbilt University, Tennes-
see, USA) to estimate the appropriate number of animals.
From former studies we anticipated the Hbcrit around a
haemoglobin concentration of 2,7 g/dL (±0.55 g/dL). We
determined a difference of 0.7 g/dL as clinical significant.
With a two-sided α of 0.05 and a power of 80 %, seven ani-
mals per group were required for the Student´s t-test to de-
tect differences in the critical haemoglobin concentration.
Between the saline and clonidine groups Hbcrit and EBV
were normally distributed, therefore differences between the
two study groups were tested using a student´s t-test for
independent samples. Distributions of macrohemodynamic
and oxygen transport data were tested by the Kolmogorov-
Smirnov test. Not all data were normally distributed;
therefore, data are presented as the median and quartiles
(Q1–Q3). A repeated-measurement ANOVA on ranks was
performed to detect differences between groups at the main
time points: BL, AM, and 25, 50, 75 %, and Hbcrit.
Post hoc analysis was performed with a Student-
Newman-Keuls (SNK) test to account for multiple com-
parisons (Statistica 5.1, StatSoft, Tulsa, OK). Statistical
significance was designated at p < 0.05 for all tests.
Results
No differences were detected at BL between the study
groups in age, sex, weight, and all other variables. Values
are median (Q1–Q3)
Primary end points: Hbcrit and EBV
The critical haemoglobin concentration (Hbcrit) was
reached at 2.2 (2.0–2.5) g · dL−1 in the saline group and 2.1
(2.1–2.4) g · dL−1 in the clonidine group (Fig. 2; n.s.). Hemo-
dilution to Hbcrit required a hydroxyethyl starch exchange
of 88 (76–106) mL · kg−1 blood in the saline group and 92
(85–95) mL · kg−1 in the clonidine group, lasting app-
roximately 83 min (n.s.). This corresponded to 115 %
(86–166 %) of the blood volume at BL in the saline
group and 121 % (108–124 %) in the clonidine group
(Fig. 2; n.s.).
Secondary end points: haemodynamics and myocardial
function
Haemodynamic data are summarized in Table 1 and in
Fig. 3. During haemodilution to Hbcrit, cardiac index
(CI) was significantly lower at BL2, 25 %, and 50 % time
points in the clonidine group. Heart rate (HR) was also
significantly lower at BL2, 25 %, and Hbcrit in the
clonidine group. Mean arterial pressure (MAP) and cor-
onary perfusion pressure (CPP) showed no intergroup
differences, despite the significantly higher values in the
clonidine group at BL2. Systemic vascular resistance
(SVRI), left ventricular systolic (LVPsys), and left
ventricular end diastolic pressure (LVPedp) were signifi-
cantly higher in the clonidine group at BL2 and at 25 %,
due to clonidine’s initial α1–mediated vasoconstriction.
The significantly higher SVRI, LVPsys, and LVPedp were
not maintained during the progression to Hbcrit.
Fig. 1 a Typical example of an oxygen consumption (VO2) recording in the course of the experimental protocol. A linear regression analysis including
the calculation of standard deviation was performed with VO2 values collected during the 60-min stabilization period. During the subsequent hemodilution
protocol, a critical limitation of DO2 was assumed, when the actually measured VO2 value decreased below the lower 3 s. b Dependency of oxygen
consumption (VO2) on oxygen delivery (DO2) during normovolemic anemia. The graph presentation of Fig. 1 panel is reflected around a vertical axis
(with the x-axis to the right of the y-axis) to match the decreasing VO2 along the timeline of panel a. In panel b DO2 decreases from left to right along
the x-axis and VO2 decreases from top to bottom along the y-axis. Despite an initial decrease of DO2, VO2 remains stable over a long period (DO2 is
independent of VO2). If a critical hemoglobin concentration (Hbcrit) is reached, VO2 starts to decrease because of a critical restriction (DO2 dependent on VO2)
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Pulmonary vascular resistance (PVRI) and mean pulmon-
ary pressure (MPAP) similarly trended in both groups and
showed no statistically significant change. The left ven-
tricular stroke work index (LVSWI) and right ventricular
stroke work index (RVSWI) were similar between the two
groups during the procedure. Left ventricular contractility
(LVPdtpmax) showed no intergroup difference, but the left
ventricular relaxation (LVPdtpmin) was significantly lower in
the clonidine group at Hbcrit.
Secondary end points: oxygen transport and tissue
oxygenation
Oxygen transport and tissue oxygenation variables are pre-
sented in Table 2 and in Fig. 4. Changes in oxygen transport
parameters and tissue oxygenation at BL2 and during he-
modilution to Hbcrit were similar between the groups.
Oxygen delivery (DO2) and oxygen consumption (VO2
mi) were significantly lower in the clonidine group at
BL2, 25 %, and 50 %. Arterial serum lactate and arterial
pH did not differ significantly between the groups and
remained stable throughout the procedure.
At BL2, arterio-venous difference in (avDO2) and
oxygen extraction ratio (O2–ER) were significantly
higher, whereas mixed-venous oxygen saturation (SvO2)
was significantly lower in the clonidine group. During
hemodilution from baseline to the study endpoint
(Hbcrit), no ventricular arrhythmia, ectopia, ST-level
changes, or other electrocardiographic arrhythmias were
encountered in either group.
Discussion
The present study indicates foremost that a high dose of
intravenous clonidine did not critically restrict acute
anaemia compensatory mechanisms in a swine model.
This is reflected in identical critical haemoglobin con-
centrations and exchangeable blood volumes observed in
both study groups.
Alpha-2 agonists mediate their cardioprotective effects by
attenuated catecholamine release and thus partially inhibited
stress-induced tachycardia. Apart from these haemodynamic
effects, α2-agonists also induce analgesia, anxiolysis, and
sedation through central presynaptic α2-adrenergic receptors
[16]. Furthermore, whole body and myocardial oxygen con-
sumption decrease under α2-agonist treatment [6].
Increased heart rate is one of the compensatory mecha-
nisms for acute dilutional anaemia, and myocardial oxygen
consumption is an important determinant of the outer
limits of this compensatory mechanism; yet, the influence
of α2-agonists on this effect and by that on anaemia
tolerance is unclear. Potentially, clonidine induced
reduction in heart rate may impair compensatory potential,
but conversely, the decreased oxygen consumption may
improve anaemia tolerance. To date, no existing study
comprehensively investigates the effects of perioperative α2-
agonists on anaemia tolerance.
Unfortunately, "anaemia tolerance" is poorly defined,
and consequently, its limits are difficult to measure. For
example, short periods of anaemia and concomitant
tissue hypoxia can be sustained without any sequelae [4],
although the individual anaemia tolerance of several
Fig. 2 Haemoglobin concentration at BL and Hbcrit. Grouped
boxplots of the arterial haemoglobin concentration (g · dL−1) at BL
and Hbcrit. The results are presented pairwise as boxplots (median
line) with whiskers (min to max). Data from the clonidine group are
coloured white, and saline group data are dark grey. No difference
was demonstrated between the groups. BL (baseline,
premedication); Hbcrit (critical haemoglobin concentration).
Exchangeable blood volume (EBV). Boxplots of the exchangeable
blood volume (mL · kg−1) until Hbcrit was reached. The results are
presented pairwise as the median and quartiles (Q1-Q3). No
differences were demonstrated between the groups. Hbcrit
(critical haemoglobin concentration)
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organs may be exceeded. Furthermore, organ specific
markers of tissue hypoxia (e. g. ECG changes, cerebral
function, urinary output) likely indicate that the outer
limit of anaemia has been surpassed at an earlier time
point, but do not reflect "anaemia tolerance" comprehen-
sively because the complete organism is not considered
[17–19].
Several studies demonstrate that a significant decline in
whole body oxygen consumption is accompanied by inad-
equate tissue oxygenation, and as a consequence this
parameter has been used regularly as measure for anaemia
tolerance [20, 21]. The corresponding haemoglobin
concentration is called "critical haemoglobin concentra-
tion (Hbcrit)." Several experimental studies have observed
haemodynamic decompensation [22], increased lactate,
and elevate catecholamine concentrations once Hbcrit was
reached that resulted in the deaths of all animals within
3 h [14]. In a recent study, we showed that Hbcrit is
accompanied by widespread tissue hypoxia in several
organs, determined by quantification of hypoxia-specific
changes in protein and RNA concentrations [20].
While this approach does not guarantee that the tissues
are undamaged by hypoxia before Hbcrit is reached, it is
apparent that upon reaching the Hbcrit, the individual
animals are similarly restricted in tissue oxygenation,
therefore, Hbcrit is a reasonable measure of global anaemia
tolerance [20].
Although no pig specific data on clonidine dosage exist,
the dosage used in our model was chosen deliberately high
compared to the rather few existing studies. While Iber et
al. established sympathicolysis with 1/10 of our dose in a
swine model [23], we failed to identify hemodynamic
changes in several dose finding experiments with this
approach. Finally, we titrated the medication up to a bolus
of 20 μg · kg−1 and a continuous rate of 15 μg · kg−1 · h−1 to
ensure a hemodynamic relevant sympatholytic effect of
the drug tested. This is bolstered by the distinct increase
in mean arterial pressure and a concomitant cardiac out-
put decline following the initial clonidine bolus. The initial
peripheral vasoconstriction is mediated by the partial af-
finity of clonidine to postsynaptic α1-receptors, until the
higher affinity to central presynaptic α2-receptors prevails
[24]. However, clonidine concentration was not measured,
and as a consequence we cannot guarantee that clonidine
concentration was consistent throughout the protocol.
The observed haemodynamic effects essentially depend
on the chosen therapeutic scheme; in daily clinical prac-
tice, clonidine dosage is much lower, and the subsequent
Fig. 3 Cardiovascular parameters in anaesthetized pigs: heart rate (HR); mean arterial pressure (MAP); cardiac index (CI); systemic vascular resistance
indexed to body surface area (SVRI) for the saline group (light grey) and the clonidine group (black) during baseline (BL1), medication (BL2), and the
percentile hemodilution steps 25, 50, and 75 % until Hbcrit (critical haemoglobin concentration). Median and quartiles (Q1-Q3). *p < 0.05
Lauscher et al. BMC Anesthesiology  (2016) 16:93 Page 6 of 10
haemodynamic changes differ essentially from our obser-
vation. After an initial, modest increase, the mean arterial
blood pressure and heart rate usually decline (Table 1,
Fig. 3). Although our model does not mimic this clinical
approach, we can deduce from our data that clonidine
only slightly influences anaemia tolerance. Hbcrit has been
observed at concentrations as low as 2.1 g · dL−1 during
our relative clonidine overdosage; the haemodynamic
changes in clonidine treated animals were comparable to
those in untreated animals during hemodilution, therefore
normal clonidine dosage will presumably only negligibly
influence haemodynamic changes during acute anaemia.
One possible explanation for the mild hemodynamic
effects observed during hemodilution might originate
from the specific compensation mechanisms during
acute anemia. In anesthetized subjects, the reduction of
oxygen content of the blood is compensated by an in-
crease in cardiac output via an increase in stroke volume
[25, 26]. This increase in stroke volume and thus cardiac
output is mainly effected by the Frank-Starling mechan-
ism: the decrease of blood viscosity due to hemodilution
reduces the peripheral resistance by shear stress induced
NO-liberation from the vessel-endothelium and thus
increases venous return [27, 28]. Therefore, in contrast
to the pathophysiology of hypovolemic/haemorrhagic
shock, in acute, normovolemic anemia oxygen delivery
to the tissues is not maintained by increased sympathetic
tone, but by the Frank-Starling mechanism [29]. This
might explain the lack of hemodynamic changes by a
drug that basically mediates its cardioprotective effects
by attenuation of catecholamine release.
Bolus clonidine administration reduced VO2 in our
model and may therefore have optimized the oxygen
consumption/delivery balance. Several authors have
similarly observed decreased VO2 and energy expend-
iture after clonidine administration. [6, 10, 30] However,
Table 2 Oxygen transport and tissue oxygenation
Group BL1 BL2 25 % 50 % 75 % Hbcrit
Hb Saline 9,0 (8,9–9,3) 8,6 (8,5–9,2) 6,0 (5,6–6,4)** 4,3 (3,9–4,5) 3,0 (2,7–3,1) 2,2 (2–2,5)
g dl−1 Clonidine 8,7 (8,5–9) 8,7 (8,4–8,9) 6,5 (6,1–6,7)** 4,2 (4,1–4,7) 3,1 (2,9–3,4) 2,1 (2,1–2,4)
paO2 Saline 90 (89–102) 89 (88–91) 93 (84–95) 93 (92–97) 94 (88–98) 108 (93–113)
mmHg Clonidine 92 (85–101) 94 (90–109) 85 (81–101) 93 (80–104) 93 (81–102) 109 (94–122)
pvO2 Saline 36 (36–38) 37 (36–44)** 41 (36–44) 35 (32–37) 36 (33–42) 26 (22–28)
mmHg Clonidine 43 (41–45) 27 (26–32)** 32 (31–36) 36 (33–40) 29 (28–31) 26 (24–32)
CaO2 Saline 12,2 (12–12,5) 11,6 (11,5–12,3) 8,3 (7,7–8,6)** 6,1 (5,4–6,2) 4,2 (3,8–4,5) 3,3 (3–3,6)
ml dl−1 Clonidine 11,8 (11,5–12,2) 11,8 (11,5–11,9) 8,9 (8,3–9,1)** 5,9 (5,7–6,4) 4,4 (4,1–4,8) 3,2 (3,1–3,4)
avDO2 Saline 3,9 (3,2–4,8) 3,4 (3,1–4,6)** 2,4 (1,8–3,2) 2,3 (1,9–2,8) 2,0 (1,9–2,2) 1,9 (1,7–2,1)
ml dl−1 Clonidine 4,7 (4,2–5,0) 6,3 (5,6–7,5)** 3,4 (2,5–4,0) 2,8 (2,3–2,8) 2,1 (1,4–2,1) 1,4 (1,1–1,9)
O2-ER Saline 31,3 (25,3–39,3) 29,7 (26,2–38,3)** 31,8 (23,6–41,5) 40,3 (37–46,4) 49,3 (48,1–49,9) 56,7 (54,1–58,2)
% Clonidine 41,2 (34,8–43,7) 58,5 (47,5–63,4)** 41,3 (31,3–44,2) 47,5 (37,4–48,2) 49,0 (28,5–50,7) 44,7 (34,2–49,1)
SaO2 Saline 98,7 (97,9–99,1) 98,5 (98,4–98,7) 98,7 (97,9–99,0) 99,0 (98,7–99,3) 99,1 (98,7–99,2) 99,3 (99,0–99,5)
% Clonidine 98,6 (98,1–99,0) 98,6 (98,0–99,1) 98,3 (98,3–98,7) 98,6 (98,0–98,9) 98,9 (98,2–99,0) 99,1 (98,9–99,1)
SvO2 Saline 68,4 (59,4–75,5) 70,0 (61,8–73,5)** 69,1 (59–76,6) 61,9 (55,4–64,4) 52,2 (51,5–53,4) 45,5 (44,3–48,3)
% Clonidine 57,8 (56,1–65,0) 41,7 (35,8–51,3)** 60,2 (55,7–68,9) 53,2 (53,2–63,5) 52,8 (50,3–71,0) 57,1 (55,5–70,0)
DO2i Saline 607 (569–623) 636 (612–677)** 512 (455–542)** 430 (393–469)** 300 (284–348) 313 (266–336)
ml min−1 m−2 Clonidine 512 (503–565) 269 (261–387)** 342 (288–418)** 281 (258–382)** 283 (228–394) 236 (190–341)
VO2im Saline 187 (180–196) 190 (183–197)** 185 (183–197)** 179 (170–196) 179 (175–193) 162 (153–181)**
ml min−1m−2 Clonidine 175 (161–193) 145 (140–159)** 181 (168–187)** 183 (174–199) 175 (161–179) 130 (122–157)**
VO2ic Saline 209 (188–247) 231 (131–259) 152 (118–211) 162 (144–198) 161 (147–178) 169 (157–201)**
ml min−1m−2 Clonidine 205 (142–223) 171 (129–236) 146 (102–157) 132 (88–146) 123 (94–166) 91 (53–158)**
Lactate Saline 1,3 (1,2–1,5) 1,3 (1,1–1,6) 1,2 (1–1,4) 1,1 (0,9–1,2) 1,1 (1–1,1) 1,6 (1,3–1,9)
mmol l−1 Clonidine 1,3 (1–1,5) 1,6 (1,2–1,6) 1,2 (0,9–1,4) 1,0 (0,8–1,2) 0,9 (0,8–1,2) 1,9 (1,4–2,1)
Parameters of oxygen transport and tissue oxygenation. All values are presented as median and quartiles (Q1–Q3) for the investigated time points BL1 (baseline,
premedication), BL2 (second baseline, after medication), 25 % (exchange of 25 % of EBV), 50 % (exchange of 50 % of EBV), 75 % (exchange of 75 % of EBV), Hbcrit
(critical hemoglobin concentration). **: p < 0.05 Saline vs. Clonidine
Hb hemoglobin concentration, PaO2 arterial oxygen partial pressure, PvO2 central venous oxygen partial pressure, CaO2 arterial oxygen content, avDO2 arterio-
venous difference in oxygen content, O2nER oxygen extraction, SaO2 arterial hemoglobin saturation, SvO2 mixed venous hemoglobin saturation, DO2i oxygen deliv-
ery indexed to BSA, VO2im measured oxygen consumption indexed to BSA, VO2ic calculated oxygen consumption, Lactate arterial serum lactate concentration, pH
negative logarithm of the molar concentration of dissolved hydronium ions in a solution
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this effect was limited in our model, occurring only at
the initial time points following administration (BL2,
25 %) where it could be attributed to severe bradycardia.
Presumably, haemodynamic changes during hemodilu-
tion were too small to influence VO2 significantly.
Underdosage of clonidine seems rather unlikely given the
observed haemodynamic changes, therefore the mecha-
nisms underlying these findings remain unknown. It is par-
ticularly unclear whether a more distinctive effect on VO2
may have caused even more pronounced anaemia tolerance.
Despite significant haemodynamic differences between
the two experimental groups, only negligible differences
were observed in oxygen transport and tissue oxygenation.
Even at very low Hb levels, there were no differences
observed in oxygen consumption, oxygen delivery, arterial
serum lactate concentration, and acid base balance
between both study groups. It can therefore be surmised
that the high clonidine dose did not critically restrict
tissue oxygenation during acute anaemia.
Several study limitations warrant discussion. We inves-
tigated the effects of clonidine on anaemia tolerance in
young, healthy pigs. Pigs are a generally accepted animal
model for hemodynamic shock and multiple studies have
shown that the limits of oxygen supply are comparable
for anesthetized, paralyzed healthy pigs and anesthetized,
paralyzed, otherwise healthy humans [4, 14, 31–34].
However, in clinical practice, patients with concomitant
cardiac risks or comorbidities are the primary popula-
tion administered perioperative α2 -adrenergic agonists
[7, 8]. Consequently, our model may differ from clinical
practice because compensatory mechanisms for acute
anaemia may be different between healthy patients and
those with significant cardiac disease. However, our re-
sults help to elucidate underlying mechanisms of anemia
tolerance during clonidine medication.
We demonstrated that Hbcrit did not differ between
control and clonidine treated animals, but this does not
indicate that moderate anaemia (Hb 8–10 g · dL−1) can
be sustained similarly in both groups in clinical
practice. Using our model we cannot rule out that in
some organs oxygen transport and tissue oxygenation
are restricted more severely by clonidine than others,
and as a result, anaemia tolerance may differ between
different organs.
Fig. 4 Oxygen transport and tissue oxygenation in anaesthetized pigs: measured oxygen consumption (VO2mi), oxygen supply (DO2i), mixed-venous
oxygen saturation of haemoglobin (SvO2), and arterial serum lactate for the saline group (light grey) and the clonidine group (black) during baseline
(BL), medication (BL2), and the percentile hemodilution steps 25, 50, and 75 % until Hbcrit (critical haemoglobin concentration). Median and quartiles
(Q1-Q3). * p < 0.05
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Dexmedetomidine was described to have even stronger
α2-selective effects than clonidine [35]. A comparison of
both drugs during acute anemia might reveal further
insight into the effects of α2-agonists during acute anemia.
β-adrenergic receptor antagonists are a common medica-
tion in elderly patients and have comparable hemodynamic
effects to α2-agonists. Perioperative ß-blockade might influ-
ence cardiac compensatory mechanisms for acute blood
losses and thus reduce the patients natural anemia toler-
ance [36].
Finally, since this study was planned using sample size cal-
culations based on the Hbcrit as the main outcome param-
eter, it might be underpowered to detect all differences in
the secondary outcome parameters (hemodynamics, oxygen
transport)- at each timepoint with multiple comparisons.
In summary, we demonstrated that the limitations of ex-
treme anaemia are independent of clonidine therapy, and
despite the study limitations, this indicates a similar an-
aemia tolerance in both experimental groups. Clinically,
these results suggest that clonidine administration alone
does not justify blood transfusion at higher haemoglobin
concentrations. However, despite these results, transfusion
at higher thresholds may still be necessary due to con-
comitant diseases that triggered clonidine therapy.
Conclusion
In conclusion, extended central sympathicolysis with clo-
nidine has no influence on the critical haemoglobin con-
centration and global anaemia tolerance in young, healthy
pigs. Based on these findings, blood transfusion cannot be
justified at considerably higher haemoglobin concentra-
tions after administering clonidine alone. This approach
supports identical transfusion schemata for patients with
or without perioperative central sympathicolysis, however
safety studies in humans, particularly cardiac compro-
mised patients, are needed to verify our results clinically.
Appendix
Body surface area (BSA in m2) was calculated according
to Holt et al. [37]
BSA ¼ k  BW 23
where BW = body weight (in kg) and k = 9.
Cardiac index was calculated as:
CI ¼ CO=BSA
where CO is cardiac output.
Peripheral vascular resistance index was calculated as:
SVRI ¼ MAP−CVPð Þ  α=CI
where SVRI is systemic vascular resistance, α is a con-
stant factor necessary to adjust the formula to the differ-
ent dimensions, CVP is central venous pressure.
Arterial O2 content (CaO2) was calculated as:
CaO2 ¼ Hb SaO2  1:34ð Þ þ paO2  0:003
Total body O2 delivery (DO2I) was calculated as follows:
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